pH-responsive, adorned nanoniosomes for codelivery of cisplatin and epirubicin: synergistic treatment of breast cancer

A Moammeri, K Abbaspour, A Zafarian… - ACS applied bio …, 2022 - ACS Publications
Combination chemotherapy has become a treatment modality for breast cancer. However,
serious side effects and high cytotoxicity associated with this combination therapy make it a …
被引用次数：44 相关文章

pH-Responsive, Adorned Nanoniosomes for Codelivery of Cisplatin and Epirubicin: Synergistic Treatment of Breast Cancer

A Moammeri, K Abbaspour… - ACS applied bio …, 2022 - pubmed.ncbi.nlm.nih.gov
Combination chemotherapy has become a treatment modality for breast cancer. However,
serious side effects and high cytotoxicity associated with this combination therapy make it a …
[HTML] nih.gov

[HTML][HTML] pH-Responsive, Adorned Nanoniosomes for Codelivery of Cisplatin and Epirubicin: Synergistic Treatment of Breast Cancer

A Moammeri, K Abbaspour, A Zafarian… - ACS Applied Bio …, 2022 - ncbi.nlm.nih.gov
Combination chemotherapy has become a treatment modality for breast cancer. However,
serious side effects and high cytotoxicity associated with this combination therapy make it a …

pH-Responsive, Adorned Nanoniosomes for Codelivery of Cisplatin and Epirubicin: Synergistic Treatment of Breast Cancer

A Moammeri, K Abbaspour, A Zafarian… - ACS APPLIED BIO …, 2022 - eprints.mui.ac.ir
Combination chemotherapy has become a treatment modality for breast cancer. However,
serious side effects and high cytotoxicity associated with this combination therapy make it a …

pH-Responsive, Adorned Nanoniosomes for Codelivery of Cisplatin and Epirubicin: Synergistic Treatment of Breast Cancer.

A Moammeri, K Abbaspour, A Zafarian… - ACS Applied bio …, 2022 - europepmc.org
Combination chemotherapy has become a treatment modality for breast cancer. However,
serious side effects and high cytotoxicity associated with this combination therapy make it a …

[引用][C] pH-Responsive, Adorned Nanoniosomes for Codelivery of Cisplatin and Epirubicin: Synergistic Treatment of Breast Cancer

A Moammeri, K Abbaspour, A Zafarian… - ACS Applied Bio …, 2022 - cir.nii.ac.jp
pH-Responsive, Adorned Nanoniosomes for Codelivery of Cisplatin and Epirubicin: Synergistic
Treatment of Breast Cancer | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ …

pH-Responsive, Adorned Nanoniosomes for Codelivery of Cisplatin and Epirubicin: Synergistic Treatment of Breast Cancer

A Moammeri, K Abbaspour, A Zafarian… - ACS APPLIED BIO …, 2022 - eprints.mui.ac.ir
Combination chemotherapy has become a treatment modality for breast cancer. However,
serious side effects and high cytotoxicity associated with this combination therapy make it a …